Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder

Damiaan Denys, Sjoerd Fluitman, Annemieke Kavelaars, Cobi Heijnen, Herman G.M. Westenberg

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Background: Obsessive-compulsive disorder (OCD) has been associated with an altered activity of the immune system. This study was carried out to investigate whether treatment with paroxetine and venlafaxine modifies the immune function in OCD and whether this modification is related to treatment outcome. Methods: Ex vivo production of TNF-α, IL-4, IL-6, IL-10, and IFN-γ in whole blood cultures, and NK-cell activity and peripheral blood NK-cell-, monocytes-, T-cell-, and B-cell- percentages were measured in 42 outpatients with OCD who participated in a 12-week, double-blind SRI trial. Results: Paroxetine and venlafaxine treatment did not affect immune parameters and clinical response was not directly related to altered activity of the immune system. Responders, defined as having a ≥25% decrease on the Y-BOCS, differed from non-responders with regard to the change of TNF-α values. Conclusions: The present results suggest that paroxetine and venlafaxine do not affect immune parameters and that clinical response is not related to altered activity of the immune system in OCD. Nonetheless, our data yielded interesting preliminary results that warrant further discussion and investigation.

Original languageEnglish (US)
Pages (from-to)355-360
Number of pages6
JournalPsychoneuroendocrinology
Volume31
Issue number3
DOIs
StatePublished - Apr 2006

Keywords

  • Cytokines
  • Immune system
  • Obsessive-compulsive disorder
  • Paroxetine
  • TNF-α
  • Venlafaxine

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint

Dive into the research topics of 'Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder'. Together they form a unique fingerprint.

Cite this